Skip to Main Content

WASHINGTON — The Food and Drug Administration is undaunted by the fact that many of its top staff are nearing retirement age and the agency has a plan to continue to buttress its ranks, both among the leadership and rank-and-file, Commissioner Scott Gottlieb said Friday.

“It is the case that about 50 percent of all the people in senior roles in [the Center for Drug Evaluation and Research] right now are nearing retirement age, where they can retire with benefits,” Gottlieb said. “We’ve been aware of that. We’ve been planning for it.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • Mr. Gottlieb. What a story? Can someone please check HUGE MESS in DENTAL Medical devices. FDA published on the Internet documents from late 90 retaping with and added stamp. I send a month ago info about this to his attention. Now he tried to send people who was part of the scam on retiremet. My case is in court against big dental lab Nobel Biocare. I never see scam presented to the public in the form FDA did. After almost 2 years after I was hurt I checked dental medical devices record 510(k) and send information to criminal investigation to fda. They didn’t respond for months.

Comments are closed.